Successful liver transplantation and treatment of recurrent hepatitis C using pegylated alpha-interferon in a patient with Churg-Strauss disease

Juergen Falkensammer; Hugo Bonatti; Rolland C Dickson; Kelly Norman; Justin Nguyen; Ronald Hinder; Jaime Aranda-Michel

doi:10.1111/j.1432-2277.2006.00415.x

Successful liver transplantation and treatment of recurrent hepatitis C using pegylated alpha-interferon in a patient with Churg-Strauss disease

Transpl Int. 2007 Feb;20(2):190-4. doi: 10.1111/j.1432-2277.2006.00415.x.

Authors

Juergen Falkensammer¹, Hugo Bonatti, Rolland C Dickson, Kelly Norman, Justin Nguyen, Ronald Hinder, Jaime Aranda-Michel

Affiliation

¹ Department of Surgery, Mayo Clinic Foundation, Jacksonville, FL 32216, USA.

PMID: 17239028
DOI: 10.1111/j.1432-2277.2006.00415.x

Abstract

Churg-Strauss disease (CSD) is a rare allergic disorder that is associated with vasculitis, peripheral eosinophilia and allergic asthma. We report on successful liver transplantation in a patient with CSD who suffered from chronic hepatitis C. Recurrent hepatitis C and CSD were ultimately managed by the application of pegylated interferon.

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / therapeutic use*
Churg-Strauss Syndrome / complications*
Female
Hepatitis C / complications*
Hepatitis C / drug therapy
Hepatitis C / surgery
Humans
Interferon alpha-2
Interferon-alpha / therapeutic use*
Liver Transplantation / adverse effects*
Middle Aged
Polyethylene Glycols / therapeutic use*
Recombinant Proteins
Recurrence

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
peginterferon alfa-2a